← Evidence map

ArticleGut and liver2016

Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis.

Jae Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 26934881